| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19d96f64aa672ec21a0200988aebc9a2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13771b597ac125e44d9e3651ef75ecc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c92d54134dd0a427016e17ce4e3083d |
| publicationDate |
2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7618950-B2 |
| titleOfInvention |
Method for treatment and prevention of herpes zoster by topical application |
| abstract |
A method for the treatment and prevention of herpes zoster using 5-[(E)-2-halogenovinyl] arabinofuranosyl uracil of the following general formula (1): n n n n n n n n n n n n wherein X represents a halogen atom. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682370-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016015731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014159731-A1 |
| priorityDate |
2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |